Abstract:The search for effective methods of cancer treatment and prevention has been a continuous effort since the disease was discovered. Recently, there has been increasing interest in exploring plants and fruits for molecules that may have potential as either adjuvants or as chemopreventive agents against cancer. One of the promising compounds under extensive research is nobiletin (NOB), a polymethoxyflavone (PMF) extracted exclusively from citrus peel. Not only does nobiletin itself exhibit anti-cancer properties, but its derivatives are also promising chemopreventive agents; examples of derivatives with anti-cancer activity include 3′-demethylnobiletin (3′-DMN), 4′-demethylnobiletin (4′-DMN), 3′,4′-didemethylnobiletin (3′,4′-DMN) and 5-demethylnobiletin (5-DMN). In vitro studies have demonstrated differential efficacies and mechanisms of NOB and its derivatives in inhibiting and killing of colon cancer cells. The chemopreventive potential of NOB has also been well demonstrated in several in vivo colon carcinogenesis animal models. NOB and its derivatives target multiple pathways in cancer progression and inhibit several of the hallmark features of colorectal cancer (CRC) pathophysiology, including arresting the cell cycle, inhibiting cell proliferation, inducing apoptosis, preventing tumour formation, reducing inflammatory effects and limiting angiogenesis. However, these substances have low oral bioavailability that limits their clinical utility, hence there have been numerous efforts exploring better drug delivery strategies for NOB and these are part of this review. We also reviewed data related to patents involving NOB to illustrate the extensiveness of each research area and its direction of commercialisation. Furthermore, this review also provides suggested directions for future research to advance NOB as the next promising candidate in CRC chemoprevention.

Nobiletin: a citrus flavonoid displaying potent physiological activity

Nobiletin a Biologically Active Phytoconstituent: Systematic Review

Hydroxylation of Flavanones by Cytochrome P450 105D7 from Streptomyces Avermitilis

Chemistry and bioactivity of nobiletin and its metabolites

The Multifunctional Effects of Nobiletin and Its Metabolites In Vivo and In Vitro

Nobiletin Exhibits Neuroprotective Effects against Mitochondrial Complex I Inhibition via Regulating Apoptotic Signaling

Nobiletin, a polymethoxylated flavone from citrus peels, induces differentiation of normal human epidermal keratinocytes

Practical Synthesis of Polymethylated Flavones: Nobiletin and Its Desmethyl Derivatives

Nobiletin as a chemopreventive natural product against cancer, a comprehensive review

Nobiletin: efficient and large quantity isolation from orange peel extract

Identification of nobiletin metabolites in mouse urine

Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention

Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes

Two New Polymethoxylated Flavones, A Class of Compounds with Potential Anticancer Activity, Isolated from Cold Pressed Dancy Tangerine Peel Oil Solids

Nobiletin and its related flavonoids with CRE-dependent transcription-stimulating and neuritegenic activities

Anti-inflammatory property of the urinary metabolites of nobiletin in mouse

Nobiletin from citrus fruit peel inhibits the DNA-binding activity of NF-κB and ROS production in LPS-activated RAW 264.7 cells

Expression and functional analysis of the nobiletin biosynthesis-related gene CitOMT in citrus fruit

Chemopreventive Effects of Nobiletin and Its Colonic Metabolites on Colon Carcinogenesis

One new lignan and one new fluorenone from Dendrobium nobile Lindl